Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Vancomycin and gentamicin interference on results of clinical chemistry tests on Abbott Architect c8000 analyzer (CROSBI ID 672820)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Nikolac, Nora ; Brenčić, Tina ; Topić, Anita Vancomycin and gentamicin interference on results of clinical chemistry tests on Abbott Architect c8000 analyzer // Clinical chemistry and laboratory medicine. 2017. str. A50-A50

Podaci o odgovornosti

Nikolac, Nora ; Brenčić, Tina ; Topić, Anita

engleski

Vancomycin and gentamicin interference on results of clinical chemistry tests on Abbott Architect c8000 analyzer

Toxic concentrations of vancomycin and gentamicin can be observed in nephrology patients. Little is known on influence of high drug concentrations on results of clinical chemistry tests. In this work we aimed to investigate interferences of vancomycin and gentamicin on results of 25 commonly measured biochemistry tests on Abbott Architect c8000. Study was carried out in University Department of Chemistry, Medical School University Hospital Sestre Milosrdnice (Zagreb, Croatia) from June to August 2016. For each drug, 10 aliquotes of serum pool were prepared. In order to cover toxic concentrations, pool serum samples were spiked with drugs to obtain: 0-50 µg/mL of gentamicin and 0-200 µg/mL of vancomycin. Measurements of biochemistry tests were done in duplicate on the analyzer Architect c8000 and drug concentrations was measured on the analyzer Architect i2000 SR (both Abbott, Illinois, USA). For each tested concentration, bias was calculated against the initial measurement. Acceptance criteria were defined as measurement uncertainty of the commercial control with value close to the measured range of the pool sample. For gentamicin interference testing, all bias values were bellow established acceptance criteria. For vancomycin, significant changes were observed for potassium, direct bilirubin and IgA. The potassium bias at the highest vancomycin concentration of 204.4 µg/mL exceeded acceptance criteria (bias=-4.5%, acceptable 4%). For direct bilirubin significant bias was detected already at low vancomycin concentration of 2.98 µg/mL (bias=9.7%, acceptable 8%). For IgA, no apparent trend was observed, and exceeded bias values are attributed to the increased method imprecision. Gentamicin didn’t interfere with the results of clinical chemistry tests. Direct bilirubin concentration is falsely increased in the presence of vancomycin, while potassium is affected at high concentrations.

interference, preanalytical phase, vancomycin, gentamicin

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

A50-A50.

2017.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Clinical chemistry and laboratory medicine

1434-6621

1437-4331

Podaci o skupu

4th EFLM-BD European Conference on Preanalytical Phase – Improving Quality of Preanalytical Phase through inovation

poster

24.03.2017-25.03.2017

Amsterdam, Nizozemska

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost